首页> 外文期刊>Genomics >Identification of a prognostic signature of epithelial ovarian cancer based on tumor immune microenvironment exploration
【24h】

Identification of a prognostic signature of epithelial ovarian cancer based on tumor immune microenvironment exploration

机译:基于肿瘤免疫微环境探索的基础上皮性卵巢癌预后特征的鉴定

获取原文
           

摘要

This study aims to develop an immune-related genes (IRGs) prognostic signature to stratify the epithelial ovarian cancer (EOC) patients. We identified 332 up- and 154 down-regulated EOC-specific IRGs. As a result, candidate IRGs were idendified to construct prognostic models respectivy for overall survial and progression-free survival. The risk score was validated as a risk factor for prognosis and was used to built a combined nomogram. According to the IRG-related prognostic model, EOC patients were divided into high- and low- risk group and were further explored their association with tumor immune microenvironment (TME). CIBERSORT algorithm showed higher macrophages M1 cell, T cells follicular helper cell and plasma cells infiltrating levels in the low-risk group. In addition, the low-risk group was found with higher immunophenoscore and distinct mutation signatures compared with the high-risk group. These findings may shed light on the development of novel immune biomarkers and target therapy of EOC.
机译:本研究旨在发展免疫相关基因(IRGS)预后签名,以分层上皮性卵巢癌(EOC)患者。我们确定了332个高度和154个下调的特定的ICG。结果,候选IRGS是致力于构建全面存活和无进展生存期的预后模型。风险评分被验证为预后的危险因素,用于建立一个组合的载体图。根据IRG相关的预后模型,EOC患者分为高风险组,并进一步探索与肿瘤免疫微环境(TME)的关联。 Cibersort算法显示出较高的巨噬细胞M1细胞,T细胞滤泡辅助细胞和血浆细胞在低风险组中浸润水平。此外,与高风险组相比,发现低风险组和不同的突变符号。这些调查结果可能阐明了新型免疫生物标志物的发展和EOC的目标治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号